AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NOVA EYE MEDICAL LTD

0.135

-0.005-3.57%

Volume:377.55K

Turnover:52.22K

Market Cap:38.45M

PE:-5.28

High:0.140

Open:0.140

Low:0.135

Close:0.140

52wk High:0.205

52wk Low:0.100

Shares:284.83M

Float Shares:240.54M

Volume Ratio:3.22

T/O Rate:0.16%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.026

EPS(LYR):-0.037

ROE:-42.35%

ROA:-17.92%

PB:2.43

PE(LYR):-3.69

Loading ...

Overview Company News Filings

GUIDANCE: (EYE) National Vision Expects Fiscal 2026 Adjusted EPS Range $0.94 - $1.09, vs. FactSet Est of $0.96

MT Newswires Live

Australia's Nova Eye Medical Jumps on Upbeat FY27 Earnings Guidance

Nova Eye Medical - Reports FY26 Sales of Us$23.7 Mln

THOMSON REUTERS

Spotlight On 3 ASX Penny Stocks With Market Caps Over A$30M

Simply Wall St.

What National Vision Holdings (EYE)'s Q1 Earnings Beat and Reaffirmed 2026 Outlook Means For Shareholders

Simply Wall St.

A Look At National Vision Holdings (EYE) Valuation After Recent Share Price Weakness

Simply Wall St.

Sector Update: Healthcare Stocks Lean Lower Pre-Bell Wednesday

MT Newswires Live

GUIDANCE: (EYE) National Vision Expects Fiscal 2026 Revenue Range $2.03B - $2.09B, vs. FactSet Est of $2.08B

MT Newswires Live

BRIEF-Nova Eye Medical Upgrades Fy26 Sales Guidance (Ex-China) To $22–23 Million

Nova Eye Medical Ltd - Upgrades FY26 Sales Guidance (Ex-China) to U$22–23 Mln

THOMSON REUTERS

Spotlight On Aurelia Metals And 2 Other ASX Penny Stocks

Simply Wall St.

A Look At National Vision Holdings (EYE) Valuation As Shares Trade Near Estimated Fair Value

Simply Wall St.

Assessing National Vision Holdings (EYE) Valuation After Earnings Turnaround And Expansion Guidance

Simply Wall St.

Assessing National Vision Holdings (EYE) Valuation After Profit Return And New Buyback Program

Simply Wall St.

GUIDANCE: (EYE) National Vision Expects Fiscal 2026 Adjusted EPS Range $0.85 - $1.09, vs. FactSet Est of $0.93

MT Newswires Live

Can National Vision (EYE) Turn Revenue Momentum Into a More Durable Earnings Story?

Simply Wall St.

BRIEF-Nova Eye Medical Says EU MDR Certification Achieved For Nova Eye's Itrack Product Portfolio

Nova Eye Medical Ltd - EU mDR Certification Achieved for Nova Eye's Itrack Product Portfolio

THOMSON REUTERS

Assessing National Vision Holdings (EYE) Valuation After Strong 1 Year Return And Recent Momentum Cooldown

Simply Wall St.

Assessing National Vision Holdings (EYE) Valuation After Recent Share Price Volatility

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/EYE.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"EYE.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EYE.AU\",,,,,undefined,":{"symbol":"EYE.AU","market":"AU","secType":"STK","nameCN":"NOVA EYE MEDICAL LTD","latestPrice":0.135,"timestamp":1787292720000,"preClose":0.14,"halted":0,"volume":377551,"delay":0,"changeRate":-0.03571428571428574,"nameEN":"NOVA EYE MEDICAL LTD","floatShares":240542047,"shares":284833284,"eps":-0.025549,"marketStatus":"Market Closed","change":-0.005,"latestTime":"08-21 16:12:00 AEST","open":0.14,"high":0.14,"low":0.135,"amount":52220,"amplitude":0.035714,"askPrice":0.14,"askSize":45500,"bidPrice":0.135,"bidSize":240361,"shortable":3,"etf":0,"ttmEps":-0.025549,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.14,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":3.2226072716858942,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"EYE.AU","preClose":0.14,"auctionPrice":0.135,"auctionVolume":22000,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292065211}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EYE.AU\",,,,,undefined,":{"symbol":"EYE.AU","floatShares":240542047,"roa":"-17.92%","roe":"-42.35%","lyrEps":-0.036626,"volumeRatio":3.2226072716858942,"shares":284833284,"dividePrice":0,"high":0.14,"amplitude":0.035714,"preClose":0.14,"low":0.135,"week52Low":0.1,"pbRate":"2.43","psRate":"1.16","week52High":0.205,"institutionHeld":0,"latestPrice":0.135,"committee":0.681663,"eps":-0.025549,"divideRate":0,"volume":377551,"delay":0,"ttmEps":-0.025549,"open":0.14,"prevYearClose":0.132,"prevWeekClose":0.145,"prevMonthClose":0.13,"prevQuarterClose":0.105,"fiveDayClose":0.145,"twentyDayClose":0.125,"sixtyDayClose":0.11,"dividendGrowthYears":0,"dividendGrowthRate":-1,"fiveYearAvgDividendRate":1.3621794871794872},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EYE.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-04","symbol":"EYE.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1785801600000,"name":null,"time":"","dateTimestamp":1785765600000,"actualEps":null},{"date":"2026-02-01","symbol":"EYE.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1769900400000,"name":null,"time":"","dateTimestamp":1769864400000,"actualEps":null},{"date":"2025-10-27","symbol":"EYE.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761519600000,"name":null,"time":"","dateTimestamp":1761483600000,"actualEps":null},{"market":"AU","date":"2024-02-13","symbol":"EYE.AU","defaultRemindTime":1707778800000,"type":"split","dateTimestamp":1707742800000,"forFactor":973737,"toFactor":1000000,"ratio":0.973737},{"date":"2023-08-28","symbol":"EYE.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693180800000,"name":null,"time":"","dateTimestamp":1693144800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EYE.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-07-21","recordDate":"2020-07-22","paymentDate":"2020-07-29","value":0.135,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EYE.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658397689","title":"GUIDANCE: (EYE) National Vision Expects Fiscal 2026 Adjusted EPS Range $0.94 - $1.09, vs. FactSet Est of $0.96","url":"https://stock-news.laohu8.com/highlight/detail?id=2658397689","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658397689?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:07","pubTimestamp":1786529229,"startTime":"0","endTime":"0","summary":"GUIDANCE: (EYE) National Vision Expects Fiscal 2026 Adjusted EPS Range $0.94 - $1.09, vs. FactSet Est of $0.96","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EYE","EYE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655586978","title":"Australia's Nova Eye Medical Jumps on Upbeat FY27 Earnings Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2655586978","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655586978?lang=en_us&edition=fundamental","pubTime":"2026-07-29 11:34","pubTimestamp":1785296041,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Nova Eye Medical jumps on upbeat FY27 earnings guidance** Shares of Nova Eye MedicalEYE.AXrise as much as 12.5% to A$0.135, set to clock its steepest intraday pct rise since July 21** Medical tech coseesFY27 sales, excluding China, between $26 million and $31 million and expects to generate to positive EBITDA** Posts total sales for the year of $23.7 million, up 26%** About 871,000 shares change hands, 3.5 times the 30-day avg** Stock is down 2% YTD, including the session's moves","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nL6N43V092:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EYE.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655834119","title":"Nova Eye Medical - Reports FY26 Sales of Us$23.7 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2655834119","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655834119?lang=en_us&edition=fundamental","pubTime":"2026-07-29 09:04","pubTimestamp":1785287072,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43U1G8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EYE.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653205739","title":"Spotlight On 3 ASX Penny Stocks With Market Caps Over A$30M","url":"https://stock-news.laohu8.com/highlight/detail?id=2653205739","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653205739?lang=en_us&edition=fundamental","pubTime":"2026-07-22 10:04","pubTimestamp":1784685894,"startTime":"0","endTime":"0","summary":"Australian shares are poised for a modest gain, buoyed by Wall Street's resilience despite challenges in the tech and semiconductor sectors. Amidst these broader market movements, penny stocks continue to capture investor interest due to their potential for growth at accessible price points. While the term \"penny stocks\" might seem outdated, these smaller or newer companies can offer unique opportunities when backed by solid financials and fundamentals.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-eye/nova-eye-medical-shares/news/spotlight-on-3-asx-penny-stocks-with-market-caps-over-a30m","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-eye/nova-eye-medical-shares/news/spotlight-on-3-asx-penny-stocks-with-market-caps-over-a30m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["WTL.AU","EYE.AU","BK7112","AMA.AU","BK7007","BK7064"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644715672","title":"What National Vision Holdings (EYE)'s Q1 Earnings Beat and Reaffirmed 2026 Outlook Means For Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2644715672","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644715672?lang=en_us&edition=fundamental","pubTime":"2026-06-17 14:24","pubTimestamp":1781677444,"startTime":"0","endTime":"0","summary":"In the past quarter, National Vision Holdings, Inc. reported first-quarter 2026 adjusted earnings of US$0.45 per share, up very large year over year, exceeding expectations on the back of strong comparable store sales driven by higher average ticket and resilient managed care demand.\nBy reaffirming its 2026 outlook for net revenue of US$2.03–US$2.09 billion and adjusted EPS of US$0.85–US$1.09, the company signaled confidence that recent sales momentum and managed care strength can support...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/4444000-choice2-main-header/1585186827172","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4444000-choice2-main-header/1585186827172"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/retail/nasdaq-eye/national-vision-holdings/news/what-national-vision-holdings-eyes-q1-earnings-beat-and-reaf","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/retail/nasdaq-eye/national-vision-holdings/news/what-national-vision-holdings-eyes-q1-earnings-beat-and-reaf","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["EYE","EYE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642436627","title":"A Look At National Vision Holdings (EYE) Valuation After Recent Share Price Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=2642436627","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642436627?lang=en_us&edition=fundamental","pubTime":"2026-06-09 01:19","pubTimestamp":1780939173,"startTime":"0","endTime":"0","summary":"Recent stock performance and business snapshot\nNational Vision Holdings (EYE) has drawn attention after the stock declined about 33% over the past month and roughly 44% over the past 3 months, prompting investors to reassess the US optical retailer’s fundamentals.\nSee our latest analysis for National Vision Holdings.\nThe recent pullback has added to a broader reset in sentiment, with the share price down 40.5% year to date and the 1-year total shareholder return falling 26.5%. This indicates...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/4444000-choice2-main-header/1585186827172","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4444000-choice2-main-header/1585186827172"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/retail/nasdaq-eye/national-vision-holdings/news/a-look-at-national-vision-holdings-eye-valuation-after-recen-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/retail/nasdaq-eye/national-vision-holdings/news/a-look-at-national-vision-holdings-eye-valuation-after-recen-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["EYE.AU","LU1559883803.SGD","BK4200","BK7007","EYE","LU0053671581.USD","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635780327","title":"Sector Update: Healthcare Stocks Lean Lower Pre-Bell Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2635780327","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635780327?lang=en_us&edition=fundamental","pubTime":"2026-05-13 21:16","pubTimestamp":1778678166,"startTime":"0","endTime":"0","summary":"Healthcare stocks were leaning lower pre-bell Wednesday, with the State Street Health Care Select Sector SPDR ETF  down 0.2% and the iShares Biotechnology ETF  declining by 0.5%.National Vision Holdings  stock was down more than 11% after the company reported fiscal Q1 revenue that missed analysts' estimates.Alto Neuroscience  shares were down more than 3% after the company posted a wider Q1 net loss.Personalis  said the Molecular Diagnostic Services Program of the Centers for Medicare & Medicaid Services has expanded coverage for the firm's NeXT Personal minimal residual disease test. Personalis stock was up more than 14% premarket.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1559883803.SGD","BK4007","XBI","PSNL","LU0053671581.USD","BK4588","BK4581","BK7007","HCSG","EYE.AU","IBB","EYE","BK4585","LU0128526141.USD","LU0029874061.USD","LU0566484027.USD","LABU","XLV","BK4137","BK4121","ANRO","BK4200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635885967","title":"GUIDANCE: (EYE) National Vision Expects Fiscal 2026 Revenue Range $2.03B - $2.09B, vs. FactSet Est of $2.08B","url":"https://stock-news.laohu8.com/highlight/detail?id=2635885967","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635885967?lang=en_us&edition=fundamental","pubTime":"2026-05-13 18:06","pubTimestamp":1778666811,"startTime":"0","endTime":"0","summary":"GUIDANCE: (EYE) National Vision Expects Fiscal 2026 Revenue Range $2.03B - $2.09B, vs. FactSet Est of $2.08B","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EYE","EYE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633998319","title":"BRIEF-Nova Eye Medical Upgrades Fy26 Sales Guidance (Ex-China) To $22–23 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633998319","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633998319?lang=en_us&edition=fundamental","pubTime":"2026-05-05 09:22","pubTimestamp":1777944121,"startTime":"0","endTime":"0","summary":"BRIEF-Nova Eye Medical Upgrades Fy26 Sales Guidance  To $22–23 MillionMay 5  - Nova Eye Medical Ltd EYE.AX:UPGRADES FY26 SALES GUIDANCE  TO U$22–23 MILLIONLAST TWELVE-MONTH SALES  $21.6 MILLION AT 30 APRIL 2026Further company coverage: EYE.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nFWN41H13R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","EYE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633671279","title":"Nova Eye Medical Ltd - Upgrades FY26 Sales Guidance (Ex-China) to U$22–23 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2633671279","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633671279?lang=en_us&edition=fundamental","pubTime":"2026-05-05 07:48","pubTimestamp":1777938526,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nFWN41H13R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","EYE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631559228","title":"Spotlight On Aurelia Metals And 2 Other ASX Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2631559228","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631559228?lang=en_us&edition=fundamental","pubTime":"2026-04-29 10:05","pubTimestamp":1777428306,"startTime":"0","endTime":"0","summary":"The Australian market is experiencing a downturn, with shares set to decline for the seventh consecutive day amid concerns over rising inflation and potential interest rate hikes. In such uncertain times, investors may look beyond the traditional big names to explore opportunities in penny stocks. Though often associated with smaller or newer companies, these stocks can offer unique growth prospects when backed by strong financials and solid fundamentals.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-eye/nova-eye-medical-shares/news/spotlight-on-aurelia-metals-and-2-other-asx-penny-stocks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-eye/nova-eye-medical-shares/news/spotlight-on-aurelia-metals-and-2-other-asx-penny-stocks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7012","IRI.AU","OBM.AU","BK7104","BK7094","EYE.AU","AMI.AU","BK4535","RPL.AU","PPS.AU","AEF.AU","BK7095","BK7088","BK7058","CGS.AU","BK7045","BK7062","BK7007","PICK","BK7132","BK7503","BK7016","BK7506","GTN.AU","EDU.AU","CLX.AU","GWA.AU","LBL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628793600","title":"A Look At National Vision Holdings (EYE) Valuation As Shares Trade Near Estimated Fair Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2628793600","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628793600?lang=en_us&edition=fundamental","pubTime":"2026-04-20 02:04","pubTimestamp":1776621846,"startTime":"0","endTime":"0","summary":"National Vision Holdings (EYE) has attracted fresh attention after recent share price moves, with the stock closing at US$25.68 and showing mixed short term returns over the past week, month, and past 3 months.\nSee our latest analysis for National Vision Holdings.\nThe recent 3.26% 1-day share price return at US$25.68 comes after a weaker patch, with a 30-day share price return of a 3.35% decline and a 90-day share price return of an 8.32% decline. The 1-year total shareholder return of...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/4444000-choice2-main-header/1585186827172","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4444000-choice2-main-header/1585186827172"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/retail/nasdaq-eye/national-vision-holdings/news/a-look-at-national-vision-holdings-eye-valuation-as-shares-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/retail/nasdaq-eye/national-vision-holdings/news/a-look-at-national-vision-holdings-eye-valuation-as-shares-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7007","EYE.AU","LU0053671581.USD","LU1559883803.SGD","EYE","LU0566484027.USD","BK4200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620495967","title":"Assessing National Vision Holdings (EYE) Valuation After Earnings Turnaround And Expansion Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2620495967","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620495967?lang=en_us&edition=fundamental","pubTime":"2026-03-17 01:25","pubTimestamp":1773681908,"startTime":"0","endTime":"0","summary":"Why the latest earnings report matters for National Vision Holdings (EYE)\nNational Vision Holdings (EYE) just posted quarterly and full year results that moved from a prior net loss to a profit, paired with revenue growth, fresh guidance, and new store expansion plans.\nSee our latest analysis for National Vision Holdings.\nAt a share price of US$26.28, the stock has seen short term pressure, with a 30 day share price return of 6.87% and a 90 day share price return of 8.11%. A 1 year total...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/4444000-choice2-main-header/1585186827172","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4444000-choice2-main-header/1585186827172"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/retail/nasdaq-eye/national-vision-holdings/news/assessing-national-vision-holdings-eye-valuation-after-earni","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/retail/nasdaq-eye/national-vision-holdings/news/assessing-national-vision-holdings-eye-valuation-after-earni","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["EYE","EYE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618647038","title":"Assessing National Vision Holdings (EYE) Valuation After Profit Return And New Buyback Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2618647038","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618647038?lang=en_us&edition=fundamental","pubTime":"2026-03-09 18:09","pubTimestamp":1773050989,"startTime":"0","endTime":"0","summary":"Why the latest earnings and buyback news matters for EYE shareholders\nNational Vision Holdings (EYE) has just reported fourth quarter and full year results that brought the company back into profit, paired with new revenue guidance, store expansion plans, and a fresh US$50 million share repurchase program.\nSee our latest analysis for National Vision Holdings.\nThe earnings return to profit, upbeat revenue guidance and new buyback sit alongside a mixed price picture, with a 7.51% year to date...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/4444000-choice2-main-header/1585186827172","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4444000-choice2-main-header/1585186827172"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/retail/nasdaq-eye/national-vision-holdings/news/assessing-national-vision-holdings-eye-valuation-after-profi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/retail/nasdaq-eye/national-vision-holdings/news/assessing-national-vision-holdings-eye-valuation-after-profi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1559883803.SGD","LU0566484027.USD","EYE","BK4200","DCF","BK7007","LU0053671581.USD","EYE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616953199","title":"GUIDANCE: (EYE) National Vision Expects Fiscal 2026 Adjusted EPS Range $0.85 - $1.09, vs. FactSet Est of $0.93","url":"https://stock-news.laohu8.com/highlight/detail?id=2616953199","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616953199?lang=en_us&edition=fundamental","pubTime":"2026-03-04 19:03","pubTimestamp":1772622215,"startTime":"0","endTime":"0","summary":"GUIDANCE: (EYE) National Vision Expects Fiscal 2026 Adjusted EPS Range $0.85 - $1.09, vs. FactSet Est of $0.93","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EYE","EYE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616370967","title":"Can National Vision (EYE) Turn Revenue Momentum Into a More Durable Earnings Story?","url":"https://stock-news.laohu8.com/highlight/detail?id=2616370967","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616370967?lang=en_us&edition=fundamental","pubTime":"2026-03-04 05:29","pubTimestamp":1772573352,"startTime":"0","endTime":"0","summary":"National Vision Holdings recently announced it would release its quarterly earnings results before the market opened on Wednesday, following a quarter in which it exceeded revenue expectations but fell short of full-year EPS guidance.\nInvestor attention is now centered on whether the company can deliver the market’s anticipated 13.4% year-on-year revenue growth, improving on the prior year’s quarterly performance.\nWe’ll now examine how expectations for stronger year-on-year revenue growth in...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/4444000-choice2-main-header/1585186827172","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4444000-choice2-main-header/1585186827172"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/retail/nasdaq-eye/national-vision-holdings/news/can-national-vision-eye-turn-revenue-momentum-into-a-more-du","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/retail/nasdaq-eye/national-vision-holdings/news/can-national-vision-eye-turn-revenue-momentum-into-a-more-du","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["EYE","EYE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616393080","title":"BRIEF-Nova Eye Medical Says EU MDR Certification Achieved For Nova Eye's Itrack Product Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2616393080","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616393080?lang=en_us&edition=fundamental","pubTime":"2026-03-03 09:18","pubTimestamp":1772500683,"startTime":"0","endTime":"0","summary":"BRIEF-Nova Eye Medical Says EU MDR Certification Achieved For Nova Eye's Itrack Product PortfolioMarch 3 (Reuters) - Nova Eye Medical Ltd EYE.AX:EU MDR CERTIFICATION ACHIEVED FOR NOVA EYE'S ITRACK PRODUCT PORTFOLIOSource Further company coverage: EYE.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nFWN3ZQ1HQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","EYE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616364667","title":"Nova Eye Medical Ltd -  EU mDR Certification Achieved for Nova Eye's Itrack Product Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2616364667","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616364667?lang=en_us&edition=fundamental","pubTime":"2026-03-03 06:14","pubTimestamp":1772489698,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nFWN3ZQ1HQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EYE.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616823667","title":"Assessing National Vision Holdings (EYE) Valuation After Strong 1 Year Return And Recent Momentum Cooldown","url":"https://stock-news.laohu8.com/highlight/detail?id=2616823667","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616823667?lang=en_us&edition=fundamental","pubTime":"2026-03-01 13:15","pubTimestamp":1772342101,"startTime":"0","endTime":"0","summary":"Event context and recent share performance\nNational Vision Holdings (EYE) has drawn investor attention recently as its share price moved to a last close of $26.97, with returns of about 2.4% over the past month and a 3.6% decline over the past 3 months.\nSee our latest analysis for National Vision Holdings.\nLooking beyond the past month, the 1 year total shareholder return of 112.2% contrasts with a modest 3.93% year to date share price return. This suggests momentum has cooled after a strong...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/4444000-choice2-main-header/1585186827172","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4444000-choice2-main-header/1585186827172"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/retail/nasdaq-eye/national-vision-holdings/news/assessing-national-vision-holdings-eye-valuation-after-stron","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/retail/nasdaq-eye/national-vision-holdings/news/assessing-national-vision-holdings-eye-valuation-after-stron","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0566484027.USD","BK7007","LU0053671581.USD","LU1559883803.SGD","BK4200","EYE.AU","EYE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612283266","title":"Assessing National Vision Holdings (EYE) Valuation After Recent Share Price Volatility","url":"https://stock-news.laohu8.com/highlight/detail?id=2612283266","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612283266?lang=en_us&edition=fundamental","pubTime":"2026-02-19 22:26","pubTimestamp":1771511170,"startTime":"0","endTime":"0","summary":"Event context and recent share moves\nNational Vision Holdings (EYE) has been trading without a specific headline catalyst, so recent price action offers the clearest signal for investors watching the optical retail name.\nThe stock closed at $27.06, with a 1 day return of 2.52% decline, 7 day return of 4.01% decline and roughly flat performance over the past month. Over the past 3 months, the share price shows a 10.04% gain. The 1 year total return is 118.40%, alongside a 3 year total return...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/4444000-choice2-main-header/1585186827172","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4444000-choice2-main-header/1585186827172"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/retail/nasdaq-eye/national-vision-holdings/news/assessing-national-vision-holdings-eye-valuation-after-recen","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/retail/nasdaq-eye/national-vision-holdings/news/assessing-national-vision-holdings-eye-valuation-after-recen","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1559883803.SGD","EYE.AU","LU0053671581.USD","BK7007","BK4200","LU0566484027.USD","DCF","EYE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}]}}